The NyokAssist device, from China, had few adverse outcomes by 30 days. More devices—and more trials—are on the way.

PCI PAL ( ($GB:PCIP) ) has shared an update. PCI Pal PLC, a global cloud provider of secure payment solutions, has released its Annual Report and ...

For optimal 1-year results, in patients with prior coronary artery bypass grafting who need percutaneous coronary ...

Overall, between 2000 and 2020, Georgia’s PCI performance against the national average fell to 87.1 percent, and the state dropped in rank all the way back to 40th. A closer look suggests that the ...

Data Centers ("365"), a leading provider of network-centric colocation, network, cloud, and other managed services, announces today a transformative partnership with Robot Network to provide ...

Brands can now bridge intent, identity, and impact, transforming engagement data into a performance-driven growth engine ...

In patients with unprotected left main stenosis, there was no difference in all-cause mortality at 10 years between patients who had percutaneous coronary intervention and those who underwent coronary ...

The clinical success of PANVIS STAR signifies that China possesses the capability for independent R&D and clinical translation in the field of interventional robotics. Its pan-vascular compatibility ...

Sonnet has launched new Thunderbolt 5 PCIe enclosures for Mac, doubling data speeds and expanding options for ...

Amid rising cybersecurity threats in the healthcare industry, Opus Interactive reaffirms leadership in delivering secure, scalable cloud infrastructure tailored for care organizations and enterprises ...

The saphenous vein grafts treated in the RCT were relatively straightforward, while the native vessels were largely CTOs.